Alioth Wins the Excellence Award at the 2025 “Startup in Shanghai” International Innovation & Entrepreneurship Competition
As one of the most influential innovation and entrepreneurship events in the city, the "Startup in Shanghai" International Innovation and Entrepreneurship Competition has always served as a vital platform for discovering and nurturing technology-based small and medium-sized enterprises. The competition venue was filled with a tense yet vibrant atmosphere. Representatives from each participating enterprise comprehensively showcased their projects' core technologies, business models, team compositions, and development plans to a judging panel composed of seasoned investors, industry technical experts, and university professors through an "8-minute pitch and Q&A + 7-minute expert questioning" format. The panel offered professional critiques and incisive questions from multiple dimensions, including technological advancement, market feasibility, team competitiveness, and financial planning, while providing valuable and constructive advice for the projects' subsequent development.
In this benchmark event showcasing Shanghai's innovation and technological vitality, Alioth demonstrated the enormous application potential of high-performance filtration membrane materials in the biopharmaceutical field, earning high recognition from the judging panel with its cutting-edge technological breakthroughs and vast industrialization prospects in the membrane materials sector.
As a comprehensive event targeting global innovation and entrepreneurship teams and enterprises, the "Startup in Shanghai" International Innovation and Entrepreneurship Competition has been held for 13 consecutive years. It has attracted over 70,000 science and technology innovation enterprises to participate, with 17,000 high-quality enterprises receiving approximately RMB 2 billion in municipal innovation funding. Nearly 920 enterprises have excelled in the national competition, becoming renowned science and technology innovation enterprises and key players in their respective industries.
With "membrane technology" as its core strategic pillar, Alioth has assembled a team of membrane material scientists from China and the United States (headquartered in Shanghai with a research and development center in Boston). Focused on overcoming critical technological bottlenecks, the company is dedicated to constructing a full-chain innovation ecosystem from basic research to industrialization, building an internationally competitive technical platform for pharmaceutical filtration materials, and providing the industry with high-quality, stable, and efficient supply chain guarantees.
- A "full-matrix" layout encompassing deep-layer cardboard, sterilization membranes, ultrafiltration membranes, and virus removal membranes, establishing a globally leading research and development platform for pharmaceutical-grade filtration membrane materials.
- Development of high-performance membrane materials that benchmark against existing imported brands while forming differentiations, catering to multi-scenario needs such as antibodies, vaccines, CGT (Cell and Gene Therapy), and small molecule drugs.
- An automated membrane material production base that seamlessly integrates technology transfer and process scale-up.
Alioth' outstanding performance at the "Startup in Shanghai" Competition is a testament to its innovation capabilities and development potential. Looking ahead, Alioth will continue to leverage its innovative advantages in the membrane technology field, driven by the mission of "underlying innovation driving pharmaceutical process upgrades," to contribute more Chinese wisdom and solutions to the global biopharmaceutical industry.
